Serological screening for specific antibodies against TORCH pathogens in reproductive-aged women in Zhangzhou, China
Frontiers in Public Health · 2025
DOI: 10.3389/fpubh.2025.1674430 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, 2025. Verfasst von Pengfei Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Collaborative Innovation Center for Translation Medical Testing and Application Technology, Department of Medical Technology, Zhangzhou Health Vocati…. Hauptthemen laut MEDLINE: Toxoplasmosis, Antibodies, Viral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
TORCH is a group of pathogens including Herpes simplex virus (HSV), Cytomegalovirus (CMV), Rubella virus (RV) and Toxoplasma gondii (TOX). Serological screening for the specific antibodies against TORCH pathogens is crucial for preventing fetal malformation and miscarriage. In this study, we analyzed the characteristics of TORCH IgM and IgG seropositivity in reproductive-aged women in Zhangzhou, China.
Methods
A total of 1,417 reproductive-aged women prior to conception attended prenatal diagnosis outpatient clinic in Zhangzhou and received the prenatal TORCH serological screening were enrolled in this study. The IgM and IgG antibodies against TORCH pathogens were detected using chemiluminescence immunoassay.
Results
The positive rates of IgM for TOX, RV, CMV and HSV-1/2 were 0.64, 2.33, 1.34 and 11.22%. The IgG seropositivity for TOX, RV, CMV, HSV-1 and HSV-2 were 3.81, 72.83, 97.46, 82.64 and 7.27%. The positive rate of HSV-1/2-IgM and TOX-IgG in 2024 were lower than that in 2023. In addition, the positive rates of RV-IgG and HSV-1-IgG were significantly higher in the women aged 30–34 years old and ≥35 years old. The CMV-IgM and HSV-2-IgG positive rates were higher in women ≥35 years old. Regarding seasonal distribution, the positive rate of HSV-1/2-IgM was significantly higher in spring (March to May) than that in winter (December to February). The seropositivity of all TORCH-IgG showed no significant differences across four seasons.
Conclusion
Our research highlights the age and seasonal distribution of TORCH seroprevalence in reproductive-aged women in Zhangzhou. These findings underscore that continuous serological surveillance is important for the prevention of congenital infections caused by TORCH pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Collaborative Innovation Center for Translation Medical Testing and Application Technology, Department of Medical Technology, Zhangzhou Health Vocational College, Zhangzhou, Fujian, China.
- Department of Laboratory Medicine, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian, China.
Zitieren
APA
Huang, P., Chen, W., Wang, G., Zeng, Y., & Guo, Y. (2025). Serological screening for specific antibodies against TORCH pathogens in reproductive-aged women in Zhangzhou, China. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2025.1674430
Vancouver
Huang P, Chen W, Wang G, Zeng Y, Guo Y. Serological screening for specific antibodies against TORCH pathogens in reproductive-aged women in Zhangzhou, China. Frontiers in Public Health. 2025. doi:10.3389/fpubh.2025.1674430
BibTeX
@article{Huang2025,
author = {Huang, Pengfei and Chen, Weide and Wang, Guowei and Zeng, Yuanjun and Guo, Yueli},
title = {Serological screening for specific antibodies against TORCH pathogens in reproductive-aged women in Zhangzhou, China},
journal = {Frontiers in Public Health},
year = {2025},
doi = {10.3389/fpubh.2025.1674430}
}
EUVIMED